HHS Extends Comment Period on Contested Autism Plan

Four Days to Review 336 Pages

WASHINGTON – Federal officials gave the public four days to review the 336-page draft of the government’s next autism strategic plan, then retreated after seven advocacy organizations objected. The comment deadline is now August 20 at 5 p.m. ET, and the approval vote has been pushed back from July 31 to late August.

The fight is over more than a deadline. HHS Secretary Robert F. Kennedy Jr. replaced the Interagency Autism Coordinating Committee’s entire membership on January 28, 2026, appointing 21 new members and reappointing none of the prior panel. The draft plan, covering 2026 to 2028, is the committee’s first since the overhaul.

The IACC advises the federal government on autism research, services, and policy under the Autism CARES Act. The committee manages about $2 billion a year in funding earmarked for autism research, services, and support, a medical communications outlet that covered the January overhaul. The plan sets no budget or reimbursement rules, but its priorities shape which questions federal agencies pursue.

The working draft, dated July 17, went public on July 21. Comments were due July 24, one week before a hybrid meeting in Rockville, Maryland, where the committee was expected to approve the plan.

Seven organizations urged the IACC to extend its public comment period to 90 days: the Profound Autism Alliance, the Autism Science Foundation, the Autism Society of America, the Coalition of Autism Scientists, the National Council on Severe Autism, Autism Speaks, and the Autistic Self Advocacy Network.

HHS did not grant the full 90 days. “After receiving feedback from autism stakeholders, the Interagency Autism Coordinating Committee (IACC) will extend the public comment period,” HHS spokesperson Emily Hilliard said in a statement reported by Disability Scoop.

Who Shaped the Draft

The organizations also object to the timing of the public’s admission. They note that the document requested feedback after the majority of it had already been written with little time for critiques.

A comment period can gather feedback on a finished draft. It cannot recreate the influence stakeholders had while the committee was still deciding what belonged in it.

The distrust traces to January. The Autism Science Foundation said the reconstituted committee was built to support predetermined conclusions rather than follow evidence, and coverage of the appointments documented members who promote environmental-toxin and vaccine-causation theories that mainstream researchers consider unsupported. In March, researchers troubled by the changes launched the Independent Autism Coordinating Committee, a parallel group with no federal authority.

The prior strategic plan, approved in January 2023, called for federal autism research funding to grow from $409.2 million in 2020 to $684 million by 2025, and shifted the plan’s language toward neutral, strengths-based terminology, according to the Organization for Autism Research.

From Behavioral Intervention to Precision Medicine

The draft keeps the IACC’s seven-question framework, spanning diagnosis, biology, causes, interventions, services, adulthood, and research infrastructure. It wraps it in a “life course” approach that runs from early development through aging.

The emphasis inside that framework has moved. According to summaries of the draft published by the newsletter Outside In and by Children’s Health Defense’s The Defender, the plan describes autism as multi-causal. It prioritizes co-occurring medical conditions, including immune and inflammatory biology, gastrointestinal health, metabolic function, and seizures, as well as research on neurodevelopmental regression.

The draft also commits to studying all possible causes of autism, which under Kennedy’s HHS includes vaccines. The plan calls for research; it makes no causal finding. Individual members’ documented vaccine-autism positions are separate from what the document itself asserts.

Its largest biomedical proposal is the National Autism Precision Therapeutics Initiative, which coordinates the FDA, CDC, and NIH around biologically defined subgroups and includes a centralized federal website, autism.gov. Service priorities include expanded special education, rural access, mental health services, augmentative communication for nonspeaking people, supportive housing, and end-of-life planning.

For ABA providers, the shift is directional, not operational. Behavioral intervention no longer anchors the plan; it now sits within a broader set of medical, communication, education, and housing priorities. The draft sets no ABA rates, revises no coverage standards, and reallocates no funding, and its recommendations carry no funding commitments, deadlines, or accountability measures.

Comments are open through August 20 at 5 p.m. ET. The rescheduled approval meeting is expected in late August; HHS had not announced a date as of publication.

AT A GLANCE

SOURCES & REFERENCES